The predictability of NPM1 mutations on the basis of GEP results is controversial: Verhaak et al (2005) did not succeed in showing, in an unsupervised analysis, a clearcut separation of NPM1 mutated from unmutated cases in more than 100 AML patients with normal karyotype. This evidence concerns the gene NPM1 and acute myeloid leukemia.